Skip to main content

Advertisement

SpringerLink
Log in

Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study is to determine whether the frequency of visits would affect disease activity and disease damage in patients with systemic lupus erythematosus (SLE). We recruited 147 patients who met the 1997 American College of Rheumatology (ACR) criteria for SLE. Patients were divided into three groups based on follow-up frequency: ≤ 6 visits/year (group 1), 6–12 visits/year (group 2), and > 12 visits/year (group 3). Disease activity and organ damage were evaluated using the SLE disease activity index (SLEDAI) and Systemic Lupus International Collaborative Clinics (SLICC)/ACR criteria, respectively. Data on disease features, patient characteristics, and treatment were retrospectively reviewed. We found that the SLICC score was significantly lower in patients with > 12 visits/year (P = 0.008), while the SLEDAI score showed no significant difference. The age at symptom onset (32.68 ± 13.53) and the age at SLE diagnosis (33.32 ± 13.81) in group 3 were significantly older than those in the other two groups. In univariate regression analysis, the frequency of visits, the age at symptom onset, and the age at SLE diagnosis were found to be associated with the SLICC scores. Visit frequency has no impact on SLE disease activity, but may be associated with less disease damage, an important outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Li LH, Pan HF, Li WX, Li XP, Xu JH, Ye DQ (2009) Study on clinical features and complications with systemic lupus erythematosus (SLE) activity in Chinese Han population. Clin Rheumatol 28(11):1301–1307

    Article  PubMed  Google Scholar 

  2. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, Maclean CH, Wofsy D et al (2009) A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 61(3):370

    Article  PubMed  PubMed Central  Google Scholar 

  3. Morand EF (2016) Connective tissue diseases: remission in SLE—are we there yet? Nat Rev Rheumatol 12(12):696–698

    Article  CAS  PubMed  Google Scholar 

  4. Ruiz E, Ramallegómara E, Elena Á, Quiñones C, Alonso V, Posada M (2014) Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. Lupus 23(4):431–435

    Article  CAS  PubMed  Google Scholar 

  5. Shen HN, Yang HH, Lu CL (2013) Temporal trends in characteristics and outcome of intensive care unit patients with systemic lupus erythematosus in Taiwan: a national population-based study. Lupus 22(6):644–652

    Article  PubMed  Google Scholar 

  6. Wu G, Jia X, Gao D, Zhao Z (2014) Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center. Clin Rheumatol 33(7):947–953

    Article  PubMed  Google Scholar 

  7. Urowitz MB, Gladman D, Abushakra M, Farewell VT (1997) Mortality studies in systemic lupus erythematosus. Results from a single center. iii. Improved survival over 24 years. J Rheumatol 24(6):1061–1065

    CAS  PubMed  Google Scholar 

  8. Urowitz MB, Kagal A, Rahman P, Gladman DD (2002) Role of specialty care in the management of patients with systemic lupus erythematosus. J Rheumatol 29(6):1207–1210

    PubMed  Google Scholar 

  9. Wallace DJ (2008) Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. Lupus 17(2):91–92

    Article  CAS  PubMed  Google Scholar 

  10. Drenkard C, Villa AR, Garciapadilla C, Pérezvázquez ME, Alarcónsegovia D (1996) Remission of systematic lupus erythematosus. Medicine 75(2):88–98

    Article  CAS  PubMed  Google Scholar 

  11. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Sanchez-Guerrero J et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39(3):363–369

    Article  CAS  PubMed  Google Scholar 

  12. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 27(2):373

    CAS  PubMed  Google Scholar 

  13. Listed N (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology ad hoc committee on systemic lupus erythematosus guidelines. Arthritis Rheum 42(9):1785

    Article  Google Scholar 

  14. Gladman DD, Koh DR, Urowitz MB, Farewell VT (2000) Lost-to-follow-up study in systemic lupus erythematosus (SLE). Lupus 9(5):363–367

    Article  CAS  PubMed  Google Scholar 

  15. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725

    Article  CAS  PubMed  Google Scholar 

  16. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640

    Article  CAS  PubMed  Google Scholar 

  17. Tunnicliffe DJ, Singhgrewal D, Kim S, Craig JC, Tong A (2015) Diagnosis, monitoring and treatment of systemic lupus erythematosus: a systematic review of clinical practice guidelines. Arthritis Care Res 67(10):1440–1452

    Article  Google Scholar 

  18. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10(1):55–60

    Article  CAS  PubMed  Google Scholar 

  19. Costedoat-Chalumeau N, Pouchot J, Guettrot-Imbert G, Guern VL, Leroux G, Marra D et al (2013) Adherence to treatment in systemic lupus erythematosus patients. Best Pract Res Clin Rheumatol 27(3):329–340

    Article  PubMed  Google Scholar 

  20. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Cervera R et al (2011) Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev 10(7):383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R et al (2010) European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69(7):1269–1274

    Article  CAS  PubMed  Google Scholar 

  22. Gladman DD, Ibañez D, Ruiz I, Urowitz MB (2013) Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort study. J Rheumatol 40(5):630–633

    Article  PubMed  Google Scholar 

  23. Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR (2013) The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol 40(6):831–841

    Article  CAS  PubMed  Google Scholar 

  24. Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH (2014) Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the lupus outcomes study. BMJ Qual Saf 23(8):659–666

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ibañez D, Gladman DD, Touma Z, Nikpour M, Urowitz MB (2011) Optimal frequency of visits for patients with systemic lupus erythematosus to measure disease activity over time. J Rheumatol 38(1):60

    Article  PubMed  Google Scholar 

  26. Bertoli AM, Fernández M, Calvo-Alén J, Vilá LM, Sanchez ML, Reveille JD et al (2006) Systemic lupus erythematosus in a multiethnic US cohort (lumina) xxxi: factors associated with patients being lost to follow-up. Lupus 15(1):19–25

    Article  CAS  PubMed  Google Scholar 

  27. Tien YC, Chiu YM, Liu MP (2016) Frequency of lost to follow-up and associated factors for patients with rheumatic diseases. PLoS One 11(3):e0150816

    Article  PubMed  PubMed Central  Google Scholar 

  28. Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Criswell LA et al (2007) Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Care Res 57(4):593–600

    Article  Google Scholar 

  29. Kulczycka L, Sysa-Jędrzejowska A, Robak E (2010) Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clin Rheumatol 29(9):991–997

    Article  PubMed  PubMed Central  Google Scholar 

  30. Daleboudt GM, Broadbent E, Mcqueen F, Kaptein AA (2011) Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus. Arthritis Care Res 63(3):342

    Google Scholar 

Download references

Acknowledgements

This work was supported by the Education Department of Shandong Province research grant (Project No. J10LF78) to Dr. Jing Dong.

Author information

Authors and Affiliations

  1. The Rheumatology and Clinical Immunology Department, The Affiliated Hospital of Qingdao University, Qingdao, China

    Huanhuan Ma, Jing Dong, Liqin Wang, Lei Zhao & Lin Pan

Authors
  1. Huanhuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liqin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lin Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Dong.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, H., Dong, J., Wang, L. et al. Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus. Clin Rheumatol 37, 101–105 (2018). https://doi.org/10.1007/s10067-017-3781-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3781-8

Keywords

Search

Navigation